Lower VO2peak (11.6 vs 14.4 ml/kg/min, p=0.039), but not exercise oscillatory ventilation, was associated with 3-month rehospitalization in patients with advanced heart failure with or without LVAD.
Observational (n=47)
No
Does left ventricular assist device (LVAD) reverse exercise oscillatory ventilation (EOV) and prevent 3-month rehospitalization in patients with advanced heart failure?
In patients with advanced heart failure, lower VO2peak rather than exercise oscillatory ventilation is associated with 3-month rehospitalization, and LVAD therapy does not appear to reverse EOV.
Abstract Background Exercise oscillatory ventilation (EOV), indicating pathological fluctuations on pulmonary arterial pressure, is associated with mortality in patients with heart failure (HF). Whether left ventricular assist device (LVAD)‐induced ventricular unloading can reverse EOV and may prevent short‐term rehospitalization has not been investigated. Methods We performed a retrospective single‐center in‐ and outpatient analysis of patients with ( n = 20, LVAD) and without ( n = 27, HF) circulatory support and reduced ejection fraction (EF, 22.8 ± 7.9%). The association of cardiopulmonary exercise testing (CPET) variables and 3 months‐rehospitalization (3MR) as a primary outcome was analyzed. Furthermore, CPET variables were compared regarding the presence of EOV (+/−). Results Lower VO 2peak (11.6 ± 4.9 ml/kg/min vs. 14.4 ± 4.3 ml/kg/min, p = 0.039), lower increase of PETCO 2 (CI = 0.049–1.127; p = 0.068), and higher VE/VCO 2 (43.8 ± 9.5 vs. 38.3 ± 10.6; p = 0.069) were associated with 3MR. Flattening of O 2 pulse (CI = 0.139–2.379; p = 0.487) had no impact on 3MR. EOV was present in 59.5% ( n = 28/47) of patients, without a significant difference between LVAD and HF patients ( p = 0.959). Patients with HF/EOV+ demonstrated significantly lower VO 2peak compared with HF/EOV− ( p = 0.039). LVAD/EOV+ displayed significantly lower EF ( p = 0.004) and fewer aortic valve opening than LVAD/EOV− ( p = 0.027). Conclusions Lower VO 2peak , but not EOV, was associated with 3MR. EOV occurred at a similar rate in LVAD and HF patients, which may illustrate insufficient unloading during exercise in chronic LVAD therapy and may contribute to the limited exercise capacity following LVAD implantation. Simultaneous CPET and right heart catheterization studies are needed to elucidate whether EOV may serve as a non‐invasive predictor of insufficient LV unloading necessitating LVAD reprograming.
Wernhart et al. (Wed,) conducted a observational in Advanced heart failure (n=47). Left ventricular assist device (LVAD) vs. Heart failure without LVAD was evaluated on 3 months-rehospitalization (3MR). Lower VO2peak (11.6 vs 14.4 ml/kg/min, p=0.039), but not exercise oscillatory ventilation, was associated with 3-month rehospitalization in patients with advanced heart failure with or without LVAD.